Acute Myeloid Leukemia News and Research

RSS
Acute Myeloid Leukemia (AML) is a rapidly progressing cancer of the blood characterized by the uncontrolled proliferation of immature blast cells in the bone marrow. The Leukemia and Lymphoma Society estimates that over 13,000 new cases of AML were diagnosed and approximately 9,000 deaths from AML occurred in the U.S. during 2007. AML is generally a disease of older adults, and the median age of a patient diagnosed with AML is about 67 years. A majority of elderly patients are not considered candidates for standard induction therapy or decline therapy, resulting in an acute need for new treatment options.
Nonhuman primate study helps explain how stem cell transplantation can kill HIV virus

Nonhuman primate study helps explain how stem cell transplantation can kill HIV virus

Scientists to discuss the latest cancer therapies, advances in PSMA PET scans and many more at ASCO

Scientists to discuss the latest cancer therapies, advances in PSMA PET scans and many more at ASCO

UVA Cancer Center receives $250,000 to develop innovative new approach to treating leukemia

UVA Cancer Center receives $250,000 to develop innovative new approach to treating leukemia

Lawyer fees draw scrutiny as Camp Lejeune claims stack up

Lawyer fees draw scrutiny as Camp Lejeune claims stack up

Break Through Cancer funds AML research at MD Anderson

Break Through Cancer funds AML research at MD Anderson

New computational method identifies routes of cellular differentiation in acute myeloid leukemia

New computational method identifies routes of cellular differentiation in acute myeloid leukemia

Research findings could help inform more effective therapies for AML

Research findings could help inform more effective therapies for AML

Mitophagy helps blood cancer cells to evade the killing effects of BH3 mimetic drug

Mitophagy helps blood cancer cells to evade the killing effects of BH3 mimetic drug

New $2.3 million NCI grant awarded to Georgia Cancer Center to improve survival of patients with AML

New $2.3 million NCI grant awarded to Georgia Cancer Center to improve survival of patients with AML

St. Jude computational biologists characterize the full spectrum of oncogenic fusions in pediatric cancer

St. Jude computational biologists characterize the full spectrum of oncogenic fusions in pediatric cancer

New research may upend long-held scientific dogma about short telomeres and cancer risk

New research may upend long-held scientific dogma about short telomeres and cancer risk

Scientists develop a marker for therapy response in acute myeloid leukemia

Scientists develop a marker for therapy response in acute myeloid leukemia

AI-assisted analysis helps find new targets for CAR-T cell therapy against acute myeloid leukemia

AI-assisted analysis helps find new targets for CAR-T cell therapy against acute myeloid leukemia

Montana considers new wave of legislation to loosen vaccination rules

Montana considers new wave of legislation to loosen vaccination rules

Detection and targeting of splicing deregulation reveal a potential strategy for pAML therapy

Detection and targeting of splicing deregulation reveal a potential strategy for pAML therapy

Study identifies a potential new treatment approach for acute myeloid leukemia

Study identifies a potential new treatment approach for acute myeloid leukemia

Research shows the benefits of screening AML patients in remission for residual disease before bone marrow transplant

Research shows the benefits of screening AML patients in remission for residual disease before bone marrow transplant

Study identifies a potential new targeted drug for treating acute myeloid leukemia

Study identifies a potential new targeted drug for treating acute myeloid leukemia

Fetal cell program appears to protect against acute myeloid leukemia

Fetal cell program appears to protect against acute myeloid leukemia

Small molecule inhibitor reverses malignant hyper-editing by an inflammation-induced protein isoform

Small molecule inhibitor reverses malignant hyper-editing by an inflammation-induced protein isoform